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tumor with metastasis: A report of two casesDear Editor,
Desmoplastic small round cell tumor (DSRCT), a rarely seen
high-grade malignant neoplasm, predominantly affects
young male adults and adolescents, and primarily appears
at the peritoneum. It is documented that 95% of DSRCTs are
located in the abdomen and pelvis, whereas in less than 5%
of cases other organs may be affected [1]. Only in a little
more than 10 cases, it is reported to be located primarily
near the testicle.
We reported two cases (a 25- and a 35-year-old male
patient) who presented with a progressive enlargement of
the right hemiscrotum and marked swelling in lymph nodes
in the abdominal cavity and retroperitoneum. One of them
had abdominal pain; neither had any previous urological
symptoms. Physical examination revealed a big, elastic,
firm mass about 3 cm  4 cm in size and several small hard
nodules distal to the tail of the epididymis. Ultrasonography
suggested weak echo masses with abundant blood supply.
Computerized tomography (CT) confirmed testicular tu-
mors, multiple peripheral lymph nodes enlargement, and
liver metastasis. Diagnosis of DSRCT was confirmed by his-
tological and immunohistochemical examinations (Fig. 1).
Fluorescence in situ hybridization (FISH) test indicated
gene translocation in one case. One patient received
radical testicular resection and hepatic arterial emboliza-
tion with diamminedichloroplatinum, cyclophosphamide,
and pirarubicin, and postsurgical chemotherapy was
applied using cyclophosphamide, pirarubicin, vindesine,
and dacarbazine; the other patient received only chemo-
therapy using cyclophosphamide, vinpocetine, and epi-
rubicin. Prognosis for both was not satisfying.
DSRCT, characterized by the formation of nests of small
round cells surrounded by fibrous tissue, is an aggressiveConflict of Statement: The authors have no conflicts of interest
relevant to this article.
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are complicated depending on the location of the tumor,
but their clinical symptoms and signs are nonspecific.
Primary paratesticular DSRCT generally manifests as
gradually enlarged painless scrotal masses. Ultrasonogra-
phy and CT can be employed as the preferred examination
methods, but the diagnosis of DSRCT still largely relies on
the histopathological, immunohistochemical, and cytoge-
netical examinations. Histopathology and immunocyto-
chemistry of the tumor have been well described [2]. The
distinctive genetic abnormalities with a specific trans-
location, i.e., t (11, 22) (p13; q12), has been demon-
strated as well, presenting a particular characteristic of
this rare neoplasm [3].
The ideal or standardized therapeutic strategy for pa-
tients with DSRCT is still not well established. However,
most scholars deem that resection and postoperative che-
moradiation therapy, with or without radiation therapy, are
the best therapeutic options. A complete resection is
seldom possible for abdominal tumors, but it can usually be
achieved for paratesticular tumors. The effect of surgical
resection on survival is not clear. Systemic chemotherapy
seems to be the most reasonable approach at present,
especially for patients who had not undergone complete
resection.
The prognosis for patients with DSRCT remains very
poor, especially for those with metastatic diseasesdonly
29% for 3-year survival and 18% for 5-year survival [4,5].
Early diagnosis and treatment are crucial for the manage-
ment of primary paratesticular DSRCT. However, recogni-
tion deficiency of this disease wildly exists. In light of this,
more efforts should be made to promote the spread of
recognition and managing measures to serve the patients
better.ed by Elsevier Taiwan LLC. All rights reserved.
Figure 1. HE and immunohistochemical staining of the biopsy specimen from the testicle masses. (A) Hematoxylin and eosin
staining demonstrates nest formation of the tumor cells in the collagen fibrous stroma (400). Immunohistochemical staining is
positive for (B) desmin (diffuse strong positive staining of tumor cell cytoplasm, 400), (C) vimentin (diffuse strong positive staining
of tumor cell cytoplasm, 400), (D) neuron-specific enolase (positive staining in part of the tumor cell cytoplasm, 400), and (E)
epithelial membrane antigen (positive staining in part of the tumor cell cytoplasm, 400).
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